BRAASCH BIOTECH - Key Persons


Dr. Keith N. Haffer - President

Job Titles:
  • Chief Scientific Officer
  • President
Dr. Keith Haffer is the driver of the vaccine science behind Braasch Biotech's novel second-generation somatostatin vaccine technology. Keith has over 30 years of experience in vaccine development and has a long track record of more than 65 successful US and International vaccine registrations and has held senior positions with multinational biopharmaceutical companies (including Sanofi and SmithKline Beecham) and is a recognized authority on feline leukemia and rabies viruses. He is the inventor of various patented and patent-pending vaccines and adjuvants for human and animal use. Keith has served on the board of directors for Immucell Corporation (NASDAQ). Keith is a graduate of Boston University (BA) and the University of Massachusetts at Amherst (MS and Ph.D.) and served on the faculty at Purdue University (School of Veterinary Medicine).

Jeralyn K. Braasch - CEO, Chairman

Job Titles:
  • CEO
  • Chairman of the Board
Immediately prior to her involvement in Braasch, she was a monthly contributor to Health Awareness in a South Dakota state-wide newspaper, city councilman for Garretson, South Dakota and its police commissioner. Preceding her move to South Dakota in 1992, she rose to the positions of Senior Supervisor in Shaklee Corporation and District Sales Manager for Avon Corporation.

Jeri Braasch - Chairman, Founder

Job Titles:
  • Chairman of the Board of Directors
  • Co - Founder